FSRPF yields 4.48% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 10
Combined, FSRPF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of FSRPF + PFE for your $10,000?
Frasers Property Limited, an investment holding company, develops, invests in, and manages a portfolio of real estate properties. The company's asset portfolio includes integrated, residential, hospitality, commercial and business parks, retail, and logistics and industrial properties in Singapore, Australia, Europe, China, Thailand, Southeast Asia, and internationally. It owns and/or operates serviced apartments and hotels in approximately 70 cities across Asia, Australia, Europe, the Middle East, and Africa. The company also acts as a sponsor of two real estate investment trusts (REITs) listed on the SGX-ST that comprises Frasers Centrepoint Trust, and Frasers Logistics & Commercial Trust focused on retail, commercial, and industrial properties; and one stapled trust listed on the SGX-ST that include Frasers Hospitality Trust focused on hospitality properties; and two REITs listed on the Stock Exchange of Thailand, which include Frasers Property (Thailand) Public Company Limited, a sponsor of Frasers Property Thailand Industrial Freehold & Leasehold REIT that focuses on industrial and logistics properties in Thailand, as well as Golden Ventures Leasehold Real Estate Investment Trust, which focuses on commercial properties. The company was formerly known as Frasers Centrepoint Limited and changed its name to Frasers Property Limited in February 2018. The company was incorporated in 1963 and is headquartered in Singapore.
Full FSRPF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.